Antibodies

29 Mar 2007 MorphoSys and Astellas Enter Antibody Partnership - Deal Seals MorphoSys's Third Japanese Pharmaceutical Alliance
29 Mar 2007 Avastin Approved in Europe for First Line Treatment of Women with Metastatic Breast Cance
28 Mar 2007 Positive Interim Phase 2 Data Reported for VEGF Trap-Eye in Age-Related Macular Degeneration
28 Mar 2007 Seattle Genetics Announces Extension of Antibody-Drug Conjugate Collaboration with Genentech
27 Mar 2007 Herceptin receives positive opinion in Europe for use in combination with an aromatase inhibitor for the treatment of patients with HER2- and hormone receptor-positive metastatic breast cancer
27 Mar 2007 European Union CHMP Recommends Approval of First and Only Biologic Treatment for Pediatric Crohn's Disease: REMICADE(R)
24 Mar 2007 MedImmune Expands Anti-Interferon-Alpha Program by Initiating Phase 1 Trial in Patients With Psoriasis
24 Mar 2007 UCB Provides Update on Cimzia for Crohn's Disease and Rheumatoid Arthritis in the US
23 Mar 2007 Studies Show Mild Hyperthermia Enhances Antitumor Effects of Alfacell's ONCONASE(R)
23 Mar 2007 MilleGen and LFB Sign Research Partnership Agreement to Develop New Generation of Therapeutic Monoclonal Antibodies
23 Mar 2007 Amgen Discontinues Vectibix(TM) Treatment In PACCE Trial Evaluating Vectibix(TM) As Part Of Triple Combination Regimen
22 Mar 2007 Peregrine Pharmaceuticals Completes Patient Enrollment in Bavituximab Combination Therapy Trial in Advanced Cancer Patients
22 Mar 2007 Phase II/III pivotal study with trifunctional antibody removab(R) shows encouraging results in malignant ascites from various cancers
22 Mar 2007 Emergent BioSolutions Files Investigational New Drug Application With FDA for Pivotal Anthrax Immune Globulin Clinical Trial
21 Mar 2007 Pain Therapeutics Cleared to Initiate Phase I Study in Metastatic Melanoma
17 Mar 2007 FDA Approves Alexion's Soliris(TM) for All Patients With PNH
17 Mar 2007 Micromet and TRACON Pharmaceuticals Sign Exclusive Worldwide License Agreement to Develop and Commercialize D93, a Humanized Antibody for Cancer Treatment
17 Mar 2007 Genmab in Research Cooperation with the Dahanca-Group
13 Mar 2007 Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With Relapsing Multiple Sclerosis
13 Mar 2007 Symphogen and Biovitrum Initiate Phase 1 Clinical Trial with The First Recombinant Polyclonal Antibody to Enter Clinical Evaluation
13 Mar 2007 TopoTarget Executes Its Licensing Option for the Development of Zemab for Breast Cancer
13 Mar 2007 Protherics to receive £10 million milestone from AstraZeneca
13 Mar 2007 New Insights Into Novel Mechanisms of Action of Genmab's HuMax-EGFr
08 Mar 2007 MAT Biopharma Announced Today the Initiation of the Phase I/II Escalating Dose of Ferritarg P(R)
07 Mar 2007 Kyowa Hakko Kogyo Co., Ltd. Licenses its in-house developed antibody KW-2871 targeting malignant melanoma to Life Science Pharmaceuticals in the US.

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top